Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Coherus Oncology, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 124 | 2 | 117 | −5 |
| Shares | 65.6M | 105.1K | 62.0M | −3.52M (−5.4%) |
| Value | $90.5M | $145.0K | $50.0M | −$40.4M (−44.7%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Coherus Oncology, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 510,628 | $412.1K | 0.00% |
| Group One Trading, L.P. | 124,915 | $100.8K | 0.00% |
| Nuveen, LLC | 95,056 | $76.7K | 0.00% |
| Prime Capital Investment Advisors, LLC | 23,483 | $19.0K | 0.00% |
| Neuberger Berman Group LLC | 18,030 | $14.6K | 0.00% |
| Wolverine Trading, LLC | 16,945 | $14.2K | 0.00% |
| Engineers Gate Manager LP | 13,212 | $10.7K | 0.00% |
| Pallas Capital Advisors LLC | 12,758 | $10.3K | 0.00% |
| Colony Group, LLC | 10,857 | $8.76K | 0.00% |
| Simplex Trading, LLC | 1,348 | $1.00K | 0.00% |
| Coldstream Capital Management Inc | 850 | $686 | 0.00% |
| Glazer Capital, LLC | 1 | $0 | 0.00% |
| Avion Wealth | 660 | $0 | 0.00% |
Sold out (18)
Institutions that held Coherus Oncology, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 5,283,292 | $7.29M |
| Disciplined Growth Investors Inc | 566,746 | $782.1K |
| Two Sigma Investments, LP | 134,138 | $185.1K |
| Savant Capital, LLC | 93,984 | $129.7K |
| Birchview Capital, LP | 82,000 | $113.2K |
| MetLife Investment Management | 73,099 | $100.9K |
| International Assets Investment Management, LLC | 45,606 | $63.8K |
| Stephenson National Bank & Trust | 25,000 | $34.5K |
| Bank of Montreal | 24,690 | $34.1K |
| Jane Street Group, LLC | 22,246 | $30.7K |
| Bayesian Capital Management, LP | 14,100 | $19.5K |
| Ethic Inc. | 11,397 | $15.7K |
| Patriot Financial Group Insurance Agency, LLC | 10,169 | $14.0K |
| Mariner, LLC | 10,000 | $13.8K |
| Baader Bank INC | 10,571 | $13.1K |
| Russell Investments Group, Ltd. | 743 | $1.02K |
| Larson Financial Group LLC | 147 | $203 |
| R Squared Ltd | 140 | $193 |
Not filed for Q1 2025 yet (2)
Institutions that held Coherus Oncology, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 95,056 | $131.2K |
| TrinityPoint Wealth, LLC | 10,038 | $13.9K |